Invesaro

Stocks Health care BDRX

NASDAQ · Health care

Biodexa Pharmaceuticals Plc (BDRX)

We have not processed filings for Biodexa Pharmaceuticals Plc yet. This page fills in on its own once we have read them.

Watch BDRX in 60 seconds

Free, no password. An email when BDRX files with the SEC.

Price
$2.46
-0.79% on the day · November 9, 2026
52-week range $2.28 to $357.60
Market cap
$126.6M

Key facts about Biodexa Pharmaceuticals Plc

Net worth
Biodexa Pharmaceuticals Plc has a market value (market cap) of $126.6M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.
Latest report
The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on March 27, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What Biodexa Pharmaceuticals Plc does

Biodexa Pharmaceuticals Plc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker BDRX.

Earnings: every quarter and the next report date

Latest SEC filings

What Biodexa Pharmaceuticals Plc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 24, 2026
    IPO registration (foreign issuer) F-1
  2. September 15, 2026
    Foreign issuer update 6-K
  3. September 11, 2026
    Foreign issuer update 6-K
  4. August 14, 2026
    Passive stake changed SCHEDULE 13G/A
  5. July 30, 2026
    IPO registration (foreign issuer) (amended) F-1/A
  6. July 29, 2026
    Foreign issuer update 6-K
  7. July 15, 2026
    IPO registration (foreign issuer) F-1
  8. July 9, 2026
    Foreign issuer update 6-K
  9. July 1, 2026
    Foreign issuer update (amended) 6-K/A
  10. June 30, 2026
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 6, the latest on March 20, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about BDRX

What does Biodexa Pharmaceuticals Plc do?

Biodexa Pharmaceuticals Plc is a company in the Health care sector, listed on NASDAQ as BDRX. Its shares trade on NASDAQ under the ticker BDRX.

What is Biodexa Pharmaceuticals Plc's net worth?

Biodexa Pharmaceuticals Plc has a market value (market cap) of $126.6M at the latest share price. A company's "net worth" usually means this market value or the shareholders' equity on its balance sheet.

When did Biodexa Pharmaceuticals Plc last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 27, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the iPO registration (foreign issuer) from September 24, 2026.

Similar companies

NTHI
Neonc Technologies Holdings, Inc.
VTVT
vTv Therapeutics Inc.
QUCY
Quantum Cyber N.V.
GNLX
GENELUX Corp
PMN
ProMIS Neurosciences Inc.
INDP
Indaptus Therapeutics, Inc.

Compare BDRX with

Compare BDRX with any company

Follow BDRX

Get an email when Biodexa Pharmaceuticals Plc files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when BDRX files with the SEC.

Where the numbers come from

Financial figures are the values Biodexa Pharmaceuticals Plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.